A. Talvensaari-mattila et al., Matrix metalloproteinase 2 immunoreactive protein appears early in cervical epithelial dedifferentiation, GYNECOL ONC, 72(3), 1999, pp. 306-311
Objective. Expression of the immunoreactive protein of matrix metalloprotei
nase 2 (MMP-2) was studied in cervical tumors representing various stages o
f cell atypia and differentiation. In this study, we evaluated whether the
expression of MMP-2 is an early or late event in the process of dedifferent
iation and cancer progression.
Methods. Paraffin tissue sections from 60 cervical neoplasias including 38
cervical intraepithelial neoplasias (CINs) and 22 early-stage (stage IB and
IIA) squamous cervical carcinomas were studied with respect to the express
ion of MMP-2 protein by using immunoperoxidase staining.
Results. The staining pattern of MMP-2 in the CIN lesions usually differed
from that in squamous carcinoma. Latent MMP-2 protein localized, in most of
the cases, to the periphery of the CIN cells, but was diffuse in the cytop
lasm of the carcinoma cells. No correlation was found between overexpressio
n of MMP-2 protein and degree of dysplasia, nor was there any association b
etween MMP-2 and human papillomavirus (HPV). High scores for MMP-2 were obs
erved only in histologically higher-grade early-stage cervical carcinomas.
The lymph node metastases derived from high-MMP-2-score primary tumors were
also positive for MMP-2. No correlation between MMP-2 staining and clinica
l course or prognosis was found.
Conclusions. MMP-2 expression is an early event during dedifferentiation an
d malignant transformation in cervical neoplasias. The pattern of staining
is different in CIN than in squamous carcinoma cells, in which overexpressi
on may correlate with the degree of anaplasia. (C) 1999 Academic Press.